Candel Therapeutics Inc share price logo

Candel Therapeutics Inc Share Price

NASDAQ: CADL

Small Cap

$5.16

+0.17

(+3.31%)

as on

Candel Therapeutics Inc Stock Performance

as on March 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.99
    $5.24
    downward going graph

    3.29%

    Downside

    1.55%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.25
    $9.08
    downward going graph

    17.64%

    Downside

    75.97%

    Upside

    downward going graph

Candel Therapeutics Inc share price movements today

Previous Close
$4.99
Open
$4.99
Volume
2.2M
Day's Low - High
$4.99 - $5.24
52 Week Low - High
$4.25 - $9.08

Candel Therapeutics Inc Historical Returns

1 Month Return
-11.37 %
3 Month Return
-9.27 %
1 Year Return
-43.49 %
3 Year Return
+ 248.95 %
5 Year Return
0 %

Candel Therapeutics Inc Stock Fundamentals & Key Indicators

Check Candel Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$342.1M

EPS (TTM)

-0.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.41

Industry PE ratio

0

PEG Ratio

0

EBITDA

-47.3M

Revenue (TTM)

31.0K

Profit Margin

0.00%

Return On Equity TTM

-64.58%

Candel Therapeutics Inc Stock Valuation

Track how Candel Therapeutics Inc P/E has moved over time to understand its valuation trends.

Candel Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-15.98x)

December 31, 2021

Industry (0.00x)

March 17, 2026

Today (-6.41x)

March 17, 2026

Highest (-0.73x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -6.41x

Candel Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Candel Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Candel Therapeutics Inc image
Candel Therapeutics Inc
BUY$342.1MNA-6.410.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.6B119.71%135.098.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$119.2B114.71%30.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.8BNA1155.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.8B52.6%17.9931.41%

Stock Returns calculator for Candel Therapeutics Inc Stock including INR - Dollar returns

The Candel Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Candel Therapeutics Inc investment value today

Current value as on today

₹64,976

Returns

₹35,024

(-35.02%)

Returns from Candel Therapeutics Inc Stock

₹41,563 (-41.56%)

Dollar Returns*

₹6,539 (+6.54%)

Analyst Recommendation on Candel Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Candel Therapeutics Inc. Average target price of $18.38

Candel Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Candel Therapeutics Inc.

What analysts predicted

71.93%UPSIDE

Target Price

$18.38

Current Price

$5.16

Analyzed by

7 Analysts

Target

$18.38

Candel Therapeutics Inc target price $18.38, a slight upside of 71.93% compared to current price of $5.16. According to 7 analysts rating.

Candel Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Candel Therapeutics Inc Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-28% versus previous 30 day period

Candel Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
1
1
-
-
1
-
-
-
Gross Profit
-5
1
0
-4
-5
0
0
0
0
Operating Income
-8
-10
-7
-8
-8
-8
-8
-11
-13
EBITDA
-8
-10
-7
-8
-8
-13
7
-4
-10
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-11
-8
-22
-10
-14
7
-4
-11
Income Tax Expense
0
0
0
0
-
-
-
-
-
Net Income
-8
-11
-8
-22
-10
-14
7
-4
-11
Net Profit Margin
0.00%
-624.72%
-462.89%
0.00%
0.00%
-1407.30%
0.00%
0.00%
0.00%

Candel Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
0
0
0
0
-
Gross Profit
-6
0
0
0
-23
0
Operating Income
-9
-13
-25
-34
-38
-33
EBITDA
-8
-13
-35
-16
-37
-52
Interest Expense
1
0
0
1
0
2
Depreciation
0
0
0
0
0
0
Income Before Tax
-8
-17
-36
-18
-37
-55
Income Tax Expense
0
4
10
-15
-
-
Net Income
-8
-17
-36
-18
-37
-55
Net Profit Margin
-6592.00%
-14144.00%
-28899.20%
-15035.20%
-122383.87%
0.00%

Candel Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-11
-8
-22
-10
-14
7
-4
-11
-29
Operating Cash Flow
-7
-8
-6
-6
-5
-8
-8
-10
-10
Investing Cash Flow
-
0
0
-
0
0
0
0
0
Financing Cash Flow
0
-1
1
1
91
-1
17
-3
43
Change in Cash
-7
-9
-4
-4
86
-10
8
-13
32

Candel Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-36
-18
-37
-55
-38
Operating Cash Flow
-9
-22
-31
-34
-27
-38
Investing Cash Flow
38
-1
-1
0
0
0
Financing Cash Flow
0
71
19
0
94
56
Change in Cash
29
47
-12
-34
67
17

Global Institutional Holdings in Candel Therapeutics Inc

Funds
Holdings
Halter Ferguson Financial Inc
1.02%
Baker Bros Advisors LP
0.65%
State Street Corp
0.94%
Northern Trust Corp
0.42%
Commonwealth Equity Services Inc
0.11%
See all

Insights on Candel Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CADL has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, CADL stock has moved up by 249.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 26.0% return, outperforming this stock by 69.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 7.37M → -29.49M (in $), with an average decrease of 153.9% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.77M → 1.0M (in $), with an average decrease of 43.7% per quarter

About Candel Therapeutics Inc

also known as advantagene. inc., we are a massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our gene mediated cytotoxic (gmci™) platform and our rqnestin34.5 platform. gmci™ is an "off-the-shelf" immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's own immune system against his or her cancer.
OrganisationCandel Therapeutics Inc
Headquarters117 Kendrick Street, Needham, MA, United States, 02494
CEODr. Paul-Peter Tak FOCIS, M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Candel Therapeutics Inc

Name

Title

Dr. William Nichols Garrett M.D., M.S.

Chief Medical Officer

Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.

President, CEO & Director

Dr. Seshu Tyagarajan Ph.D.

Chief Technical & Development Officer

Dr. Francesca Barone M.D., Ph.D.

Chief Scientific Officer

Mr. Charles Schoch

Senior VP, CFO, Principal Accounting Officer, Treasurer & Secretary

Ms. Ileen B. Winick

Chief People Officer

Ms. Susan Stewart J.D., L.L.M.

Chief Regulatory Officer

FAQs

What is Candel Therapeutics Inc share price today?

Candel Therapeutics Inc share price today is $5.16 as on at the close of the market. Candel Therapeutics Inc share today touched a day high of $5.24 and a low of $4.99.

What is the 52 week high and 52 week low for Candel Therapeutics Inc share?

Candel Therapeutics Inc share touched a 52 week high of $9.08 on and a 52 week low of $4.25 on . Candel Therapeutics Inc stock price today i.e. is closed at $5.16,which is 43.17% down from its 52 week high and 21.41% up from its 52 week low.

What is Candel Therapeutics Inc's market capitalisation today?

Candel Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Candel Therapeutics Inc Stock (CADL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Candel Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Candel Therapeutics Inc Shares that will get you 0.2907 shares as per Candel Therapeutics Inc share price of $5.16 per share as on March 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Candel Therapeutics Inc Stock (CADL) from India?

Indian investors can start investing in Candel Therapeutics Inc (CADL) shares with as little as ₹92.369 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹923.69 in Candel Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Candel Therapeutics Inc share’s latest price of $5.16 as on March 18, 2026 at 1:29 am IST, you will get 1.9380 shares of Candel Therapeutics Inc. Learn more about fractional shares .